ProMIS Neurosciences, Inc. (PMN)

NASDAQ: PMN · IEX Real-Time Price · USD

1.990

-0.140 (-6.57%)

At close: Jul 19, 2024, 4:00 PM

2.110

+0.120 (6.03%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

ProMIS Neurosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-11.89	-13.21	-18.06	-9.79	-4.25
Depreciation & Amortization	0.02	0.02	0.01	0.05	0.01
Share-Based Compensation	0.2	0.27	0.49	0.52	0.35
Other Operating Activities	-6.91	2.08	0.53	-0.08	0.65
Operating Cash Flow	-18.57	-10.84	-17.03	-9.31	-3.23
Capital Expenditures	0	0	-0	0.09	-0.08
Change in Investments	-0	-0	0	-0	-0
Other Investing Activities	-	-	-	0	-0
Investing Cash Flow	-0	-0	-0	0.09	-0.08
Share Issuance / Repurchase	-0.32	17.75	6.49	18.61	1.61
Debt Issued / Paid	0	0	0	6.92	0
Other Financing Activities	0	0	-	-	1.26
Financing Cash Flow	-0.32	17.75	6.49	25.52	2.86
Exchange Rate Effect	-0.2	-0.18	-0.53	-0.18	-0.02
Net Cash Flow	-0.83	6.72	-11.07	16.14	-0.47
Free Cash Flow	-18.57	-10.84	-17.04	-9.21	-3.31
Free Cash Flow Per Share	-0.95	-0.88	-2.27	-1.59	-0.70

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).